Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | GGT1 | P19440 | 2/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1512926 | 1.00 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL1512928 | 1.00 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL8420686 | 1.00 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL1607862 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL196983 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL13746293 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL5819946 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL5823952 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL13753646 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL305904 | 0.84 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0884390-B1 | Method for producing an optically active compound | KYOWA HAKKO KOGYO KK (JP) | 2006-05-10 | — | — | EP | claimed |
| US-20020006645-A1 | Method for producing optically active compound | HASHIMOTO SHIN-ICHI (JP) | 2002-01-17 | — | — | US | claimed |
| US-6207427-B1 | ALLOWING RECOMBINANT MICROORGANISM CARRYING RECOMBINANT DNA HARBORING (S)-4-HYDROXY-2-KETOGLUTARIC ACID ALDOLASE GENE TO ACT ON SUGAR AND GLYOXYLIC ACID IN AN AQUEOUS MEDIUM, AND COLLECTING OPTICALLY ACTIVE (S)-4-HYDROXY-2-KETOGLUTARIC ACID | KYOWA HAKKO KOGYO, LTD. (JP) | 2001-03-27 | — | — | US | claimed |
| EP-0692539-B1 | Process for producing an optically active gamma-hydroxy-L-glutamic acid | KYOWA HAKKO KOGYO KK (JP) | 1999-09-22 | — | — | EP | claimed |
| EP-0884390-A2 | Method for producing an optically active compound | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-12-16 | — | — | EP | claimed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | disclosed |
| US-12410213-B2 | Polypeptides self-assembling into nanoparticles | ETH ZËRICH (CH) | 2025-09-09 | — | — | US | disclosed |
| EP-3833676-B1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2025-05-28 | — | — | EP | disclosed |
| CN-112533938-B | Polypeptides self-assembled into nanoparticles | 苏黎世联邦理工学院 | 2025-04-25 | — | — | CN | disclosed |
| EP-4103160-B1 | NANOPARTICLES ENCAPSULATING SMALL MOLECULES | ETH ZUERICH (CH) | 2024-06-26 | — | — | EP | disclosed |
| US-20230080270-A1 | NANOPARTICLES ENCAPSULATING SMALL MOLECULES | ETH ZURICH (CH) | 2023-03-16 | — | — | US | disclosed |
| EP-4103160-A1 | NANOPARTICLES ENCAPSULATING SMALL MOLECULES | ETH Zurich (CH) | 2022-12-21 | — | — | EP | disclosed |
| CN-112533938-A | Polypeptides that self-assemble into nanoparticles | 苏黎世联邦理工学院 | 2021-03-19 | — | — | CN | disclosed |
| WO-2020030654-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH Zürich (CH) | 2020-02-13 | — | — | WO | disclosed |
| US-20150064714-A1 | Polypeptides containing a modified fragment of the peptide IF1 | LIFESEARCH (FR) | 2015-03-05 | — | — | US | disclosed |
| EP-0884390-B1 | Method for producing an optically active compound | KYOWA HAKKO KOGYO KK (JP) | 2006-05-10 | — | — | EP | disclosed |
| US-6365381-B2 | PRODUCING (S)-4-HYDROXY-2-KETOGLUTARIC ACID AND COMPOUNDS WHICH ARE FORMED BY BIOSYNTHESIS FROM THIS PRECURSOR USING RECOMBINANT MICROORGANISM CARRYING A RECOMBINANT DNA HARBORING THIS ACID ALDOLASE GENE, SUGAR AND GLYOXYLIC ACID | KYOWA HAKKO KOGYO, LTD. (JP) | 2002-04-02 | — | — | US | disclosed |
| US-20020006645-A1 | Method for producing optically active compound | HASHIMOTO SHIN-ICHI (JP) | 2002-01-17 | — | — | US | disclosed |
| US-6207427-B1 | ALLOWING RECOMBINANT MICROORGANISM CARRYING RECOMBINANT DNA HARBORING (S)-4-HYDROXY-2-KETOGLUTARIC ACID ALDOLASE GENE TO ACT ON SUGAR AND GLYOXYLIC ACID IN AN AQUEOUS MEDIUM, AND COLLECTING OPTICALLY ACTIVE (S)-4-HYDROXY-2-KETOGLUTARIC ACID | KYOWA HAKKO KOGYO, LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0884390-A2 | Method for producing an optically active compound | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | SLC7A5 192/4885SLC1A1 223/4885SLC1A3 205/4885 |
| US-20150064714-A1 | Polypeptides containing a modified fragment of the peptide IF1 | NGLY1, TAP1, F13A1 | SLC7A5 3253/4885SLC1A1 1325/4885SLC1A3 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.